Around 3mil shares buy order by one on 63, page-44

Well the more important question now is what will happen this year FY16 - we aready saw one quarter.

You have to assume that employee benefits willl increase markedly next year as we will surely have more employees. What will the employee benefit figure be if they have another 224% increase... Lets say even if they cut back their benefit it can still be around 16-18 million for FY16 with extra staff put on next year. Whos going to pay for that as cardiocel is still not in that parabolic phase of growth.

And if it is around the 16-18 million figure what is the acceptable revenue ?? Lets assume quicker growth and we get to 15 million or 5/6 million gross profit ... Still bleeding as I seee it.

There will be a lot of questions raised, rest assured, of managements performance if Ian Frazer doesnt pull a rabbit out of the bag and save their blushes on these employee benefits.